DrugPatentWatch Database Preview
INFUMORPH Drug Profile
» See Plans and Pricing
When do Infumorph patents expire, and what generic alternatives are available?
Infumorph is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in INFUMORPH is morphine sulfate. There are twenty-three drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
US ANDA Litigation and Generic Entry Outlook for Infumorph
A generic version of INFUMORPH was approved as morphine sulfate by HOSPIRA on May 11th, 1988.
Summary for INFUMORPH
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 17 |
| Clinical Trials: | 3 |
| Patent Applications: | 8,342 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for INFUMORPH |
| DailyMed Link: | INFUMORPH at DailyMed |
Recent Clinical Trials for INFUMORPH
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Abdelrady S Ibrahim, MD | Phase 2 |
| Duke University | Phase 4 |
| National Institutes of Health (NIH) | Phase 4 |
Pharmacology for INFUMORPH
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
US Patents and Regulatory Information for INFUMORPH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | INFUMORPH | morphine sulfate | INJECTABLE;INJECTION | 018565-003 | Jul 19, 1991 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Hikma | INFUMORPH | morphine sulfate | INJECTABLE;INJECTION | 018565-004 | Jul 19, 1991 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
